Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: RTX stock price vs PHG: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PHG's multiple
Needs PHG P/E.
Implied fair value · at RTX's multiple
Needs RTX P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
USD conversion input: 1 EUR = 1.121400 USD. FX date unavailable.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
RTX CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
KONINKLIJKE PHILIPS NV · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
General Electric Company
RTX vs GE
HONEYWELL INTERNATIONAL INC
RTX vs HON
Parker-Hannifin Corp
RTX vs PH
Spirit AeroSystems Holdings, Inc.
RTX vs SPR
TransDigm Group INC
RTX vs TDG
GE HealthCare Technologies Inc.
RTX vs GEHC
HOLOGIC INC
RTX vs HOLX
BOSTON SCIENTIFIC CORP
RTX vs BSX
INTUITIVE SURGICAL INC
RTX vs ISRG
ZIMMER BIOMET HOLDINGS, INC.
RTX vs ZBH
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe RTX can sustain its 9.7% revenue growth and convert that into earnings that justify a 44.9x P/E, then hold or add selectively; otherwise, the valuation gap versus PHG and the DCF range suggests caution because the current price sits well above both the implied price and the DCF estimates.
RTX trades at a premium on earnings versus PHG, with a 44.9x P/E compared with PHG's 24.4x, which helps explain the model's implied downside to $121.07 from the current $222.70 price. However, the cross-check is not one-sided because RTX is cheaper on EV/EBITDA and EV/Revenue than PHG, suggesting the gap depends heavily on the earnings and balance-sheet lens used.
Supporting Metrics
